NO by endothelial nitric oxide synthase (NOS3) is implicated in vascular smooth muscle relaxation and mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels, which may explain the many complications occurring in COVID-19 patients [51]. Here, NOS3 is linked to COVID-19.